These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 35812727)
1. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma. Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G Front Genet; 2022; 13():922358. PubMed ID: 35812727 [No Abstract] [Full Text] [Related]
2. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role. Zhong S; Chen S; Lin H; Luo Y; He J BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670 [TBL] [Abstract][Full Text] [Related]
3. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma. Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation. Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma. Hong P; Huang W; Du H; Hu D; Cao Q; Wang Y; Zhang H; Tong S; Li Z; Tong M Front Genet; 2022; 13():1009555. PubMed ID: 36406128 [No Abstract] [Full Text] [Related]
6. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
7. miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma. Yu L; Xiang L; Feng J; Li B; Zhou Z; Li J; Lin Y; Lv Y; Zou D; Lei Z; Zhang J J Cancer; 2018; 9(20):3651-3659. PubMed ID: 30405833 [No Abstract] [Full Text] [Related]
8. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma. Qiu X; Chen Y; Zhu X; Gong Z; Yu F; Zhang P; Song Y; Li H Asian Pac J Cancer Prev; 2023 Apr; 24(4):1275-1287. PubMed ID: 37116150 [TBL] [Abstract][Full Text] [Related]
9. m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma. Chen M; Nie Z; Gao Y; Cao H; Zheng L; Guo N; Peng Y; Zhang S Front Pharmacol; 2022; 13():900006. PubMed ID: 36147333 [No Abstract] [Full Text] [Related]
10. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer. Dai D; Zhuang H; Shu M; Chen L; Long C; Wu H; Chen B Heliyon; 2024 Apr; 10(8):e29326. PubMed ID: 38628712 [TBL] [Abstract][Full Text] [Related]
11. Development and Validation of Anoiki-Related Lncrna Signature Prediction Model for KIRC Prognosis. Su Y; Yang J Comb Chem High Throughput Screen; 2024 Jan; ():. PubMed ID: 38305400 [TBL] [Abstract][Full Text] [Related]
12. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Front Oncol; 2021; 11():663263. PubMed ID: 34123820 [TBL] [Abstract][Full Text] [Related]
13. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J; Liang Y; Gu JJ; Huang Y; Wang B Front Genet; 2022; 13():991162. PubMed ID: 36353118 [No Abstract] [Full Text] [Related]
14. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma. Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X Front Immunol; 2022; 13():934387. PubMed ID: 35958561 [TBL] [Abstract][Full Text] [Related]
15. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration. Zheng D; Zhang Y; Xia Y; Cheng F Front Oncol; 2022; 12():840410. PubMed ID: 35371994 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma. Zhou X; Liu G; Xu M; Ying X; Li B; Cao F; Cheng S; Xiao B; Cheng M; Liang L; Jia M; Li W; Liu J; Li Z Mol Carcinog; 2022 May; 61(5):508-523. PubMed ID: 35129856 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy. Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P Front Oncol; 2022; 12():1024956. PubMed ID: 36439501 [TBL] [Abstract][Full Text] [Related]
18. Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation. Zhang X; Qin X; Yu T; Wang K; Chen Y; Xing Q Front Genet; 2022; 13():974726. PubMed ID: 36338996 [No Abstract] [Full Text] [Related]
19. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma. Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097 [TBL] [Abstract][Full Text] [Related]
20. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]